Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial cell wall and cytoplasmic membrane anionic components comprise a diverse group of negatively charged molecules essential for bacterial viability and structural integrity. In Gram-negative bacteria, the primary anionic component is lipopolysaccharide (LPS) located in the outer membrane, while Gram-positive bacteria utilize wall teichoic acids (WTA) and lipoteichoic acids (LTA) to maintain a negative surface charge. Additionally, both groups contain anionic phospholipids, such as phosphatidylglycerol and cardiolipin, within their cytoplasmic membranes that contribute to the overall electronegativity of the cell envelope. These components play critical roles in ion homeostasis, particularly the sequestration of divalent cations like magnesium, and serve as protective barriers against environmental threats. Therapeutically, these anionic structures are the primary targets for several classes of rapidly bactericidal antibiotics, including polymyxins and lipopeptides like daptomycin. These drugs typically possess cationic regions that are electrostatically attracted to the anionic bacterial surface, allowing them to bypass host cells, which generally have zwitterionic outer membranes. Upon binding, these agents disrupt membrane potential or physical integrity, leading to rapid cell death. However, the clinical use of such drugs is often limited by toxicity concerns, such as nephrotoxicity, and the potential for bacteria to evolve resistance by modifying their surface charge to repel cationic molecules.
Drugs target these components through electrostatic attraction between their cationic moieties and the anionic bacterial surface. This interaction leads to membrane insertion, depolarization, pore formation, and physical disruption of the cell envelope, ultimately causing leakage of intracellular contents and cell death. Some agents also inhibit cell wall synthesis by sequestering lipid-linked precursors associated with these anionic structures.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell wall and cytoplasmic membrane anionic components.